A levee broke around noon in Tukwila prompting the National Weather Service to issue a flash flood warning. Folks have been under a Go-Now alert since the weekend. Political malpractice: Johnson faces ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. Earlier this month, Google researchers ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...

The Writers Guild of America East is telling its CBS News members that the network assured them that they won’t face discipline if they decline to respond to new editor-in-chief Bari Weiss’ memo to ...

“I hope you are as excited as I am about the prospect of elevating CBS News to its rightful place as No. 1: the most trusted and most consumed news source in the nation,” Weiss wrote. “So, I’m ...

Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. It's common for clinical-stage biotech companies to post net ...